default author photo

Jian-Piao Cai

The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases

SCHOLARLY PAPERS

3

DOWNLOADS

253

TOTAL CITATIONS

0

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Immune Imprinting with Ancestral SARS-CoV-2 Strain Induced Potent Neutralizing Activity Against Omicron Sublineages BA.2, BA.2.12.1 and BA.4/5

Number of pages: 24 Posted: 01 Sep 2022
Xiaojuan Zhang, Lin-Lei Chen, Syed Muhammad Umer Abdullah, Jian-Piao Cai, Anthony Raymond Tam, Wing-Ming Chu, Wan-Mui Chan, Jonathan Daniel Ip, Allen Wing-Ho Chu, Lu Lu, Brain Pui-Chun Chan, Yan Zhao, Kwok-Hung Chan, Kwok-Yung Yuen, Vincent Chi-Chung Cheng, Ivan Fan Ngai Hung and Kelvin Kai-Wang To
The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - Division of Infectious Disease, The University of Hong Kong - Division of Infectious Disease, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - School of Clinical Medicine and The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases
Downloads 125 (576,708)

Abstract:

Loading...

COVID-19, SARS-CoV-2, Omicron variant, BA.2.12.1, BA.4, BA.5 sublineages, immune imprinting, vaccine, neutralizing antibody, hybrid immunity

2.

A Phase 1, Randomized, Double-Blinded, Placebo-Controlled and Dose-Escalation Study to Evaluate the Safety and Immunogenicity of the Intranasal Delns1-nCoV-RBD LAIV for COVID-19 in Healthy Adults

Number of pages: 32 Posted: 20 Jun 2022
Ricky Rui-Qi Zhang, Kwok-Hung Chan, Pui Wang, Runhong Zhou, Henry Kwong-Chi Yau, Creany Ka-Wai Wong, Meena Wai-Lam Au, Anthony Raymond Tam, Chi-Tao Ng, Matthew Kwok-Chung Lou, Na Liu, Haode Huang, Shaofeng Deng, Chun-Yee Tam, Ying Liu, Teng Long, Hoi-Wah Tsoi, Miko KW Ng, Jian-Piao Cai, Kelvin Kai-Wang To, Man-Fung Yuen, Zhiwei Chen, Honglin Chen, Kwok-Yung Yuen and Ivan Fan Ngai Hung
The University of Hong Kong - Li Ka Shing Faculty of Medicine, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - Clinical Trials Centre, The University of Hong Kong - Clinical Trials Centre, The University of Hong Kong - Clinical Trials Centre, The University of Hong Kong - Division of Infectious Disease, The University of Hong Kong - Clinical Trials Centre, The University of Hong Kong - Clinical Trials Centre, The University of Hong Kong - AIDS Institute, The University of Hong Kong - AIDS Institute, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - Queen Mary Hospital, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases and The University of Hong Kong - School of Clinical Medicine
Downloads 75 (837,727)

Abstract:

Loading...

Phase-1, intranasal, DelNS1-nCoV-RBD LAIV, COVID-19

3.

The Impact of Vaccine Type and Booster Dose on the Magnitude and Breadth of Sars-Cov-2-Specific Mucosal Iga

Number of pages: 28 Posted: 15 May 2024
Hoi-Wah Tsoi, Miko Ka-Wai Ng, Jian-Piao Cai, Rosana Wing-Shan Poon, Brian Pui-Chun Chan, Kwok-Hung Chan, Anthony Raymond Tam, Wing-Ming Chu, Ivan Fan Ngai Hung and Kelvin Kai-Wang To
The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, Government of the Hong Kong Special Administrative Region - Hospital Authority, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - Division of Infectious Disease, The University of Hong Kong - Division of Infectious Disease, The University of Hong Kong - School of Clinical Medicine and The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases
Downloads 53 (1,041,696)

Abstract:

Loading...

COVID-19 vaccine, SARS-CoV-2, Omicron variant, mucosal immunity, saliva, IgA